AGEs induce oxidative stress and activate protein kinase C-β(II) in neonatal mesangial cells

American Journal of Physiology - Renal Physiology

Volumn 278, Issue 4 47-4, 2000, Pages

  Scivittaro, Vincenzo ^a   Ganz, Michael B ^a   Weiss, Miriam F ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Advanced glycation end products; Intracellular oxidative stress; Mesangial cells; Neonatal rat mesangial cells; Protein kinase C isoforms

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CALCIUM ION; FLUORESCEIN DIACETATE; ISOENZYME; PROTEIN KINASE C;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; ENZYME ACTIVATION; IMMUNOFLUORESCENCE; MESANGIUM CELL; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; WESTERN BLOTTING;

EID: 0033996388     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.2000.278.4.f676     Document Type: Article

References (41)

1. II (PKC) antisense oligonucleotides (oligos) on proliferation of rat glomerular mesangial cells (Abstract). J Am Soc Nephrol 6: 782, 1995.
2. Araki N, Higashi T, Mori T, Shibayama R, Kawabe Y, Kodama T, Takahashi K, Shichiri M, and Horiuchi S. Macrophage scavenger receptor mediates the endocytic uptake and degradation of advanced glycation end products of the Maillard reaction. Eur J Biochem 230: 408-415, 1995.
3. Ayo S, Radnick R, Glass W, Garoni J, Rampt E, Appling D, and Kreisberg J. Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high-glucose medium. Am J Physiol Renal Fluid Electrolyte Physiol 260: F185-F191, 1991.
4. Beisswenger P, Moore L, and Brink-Johnson T. Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy. J Clin Invest 92: 212-217, 1993.
5. Bierhaus A, Ilmer T, Kasper M, Luther T, Quehenberger P, Tritschler H, Wahl P, Ziegler R, Muller M, and Nawroth P. Advanced glycation end product (AGE) mediated induction of tissue factor in cultured endothelial cells is dependent on RAGE. Circulation 96: 2262-2271, 1997.
6. Chini C. Compartmentalization of cAMP signaling in mesangial cells by phosphodiesterase isozymes PDE3 and PDE4. Regulation of superoxidation and mitogenesis. J Biol Chem 272: 9854-9859, 1997.
7. DeRubertis F and Craven P. Activation of protein kinase C in glomerular cells in diabetes. Diabetes 43: 1-8, 1994.
8. Dlugosz A, Mischak H, Mushinski J, and Yuspa S. Transcripts encoding protein kinase C-α, -δ, -I, -ζ, -ε are expressed in basal and differentiating mouse keratinocytes in vitro and exhibit quantitative changes in neoplastic cells. Mol Carcinog 5: 86-292, 1992.
9. Doi T, Vlassara H, Kirstein M, Yamada Y, Striker G, and Striker L. Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor. Proc Natl Acd Sci USA 89: 2873-2877, 1992.
10. Dunn J, McCance D, Thorpe S, Lyons T, and Baynes J. Age dependent accumulation of Nε(carboxymethyl)lysine and Nε(carboxymethyl)hydroxylysine in human skin collagen. Biochemistry 30: 1205-1210, 1991.
11. Friedlander M, Wu Y, Elgawish A, and Monnier V. Early and advanced glycosylation end products: kinetics of formation and clearance in peritoneal dialysis. J Clin Invest 97: 728-735, 1996.
12. Ganz M, Kasner S, and Unwin R. Glomerular mesangial cells in culture are both a source and target of nitric oxide. Am J Physiol Renal Fluid Electrolyte Physiol 268: F1081-F1086, 1995.
13. Ganz M, Pekar S, Perfetto M, and Sterzel R. Arginine vasopressin stimulates glomerular mesangial cell proliferation. Am J Physiol Renal Fluid Electrolyte Physiol 254: F898-F906, 1988.
14. i of mesangial cells. Am J Physiol Renal Fluid Electrolyte Physiol 259: F269-F278, 1990.
15. Ganz M, Saxena R, Hawkins K, and Sedor J. PDGF and IL-1 induce and activate specific protein kinase C isoforms in mesangial cells. Am J Physiol Renal Fluid Electrolyte Physiol 271: F108-F113, 1996.
16. Glomb M and Monnier V. Mechanism of protein modification by glyoxal and glycoaldehyde, reactive intermediates of the Maillard reaction. J Biol Chem 270: 10017-10026, 1995.
17. Gorman AM. Use of flow cytometry techniques in studying mechanisms of apoptosis in leukemic cells (Abstract). Cytometry 29: 97, 1997.
18. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440-3450, 1985.
19. Ishii H, Jirousek M, Koya D, Takagi C, Xia P, Clermont A, Bursell S, Kern T, Ballas L, Heath W, Stramm L, Feenre E, and King G. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC β inhibitor. Science 272: 728-731, 1996.
20. Jakubowski W and Bartosz G. Estimation of oxidative stress in Saccharomyces cerevisae with fluorescent probes. Int J Biochem Cell Biol 29: 1297, 1997.
21. Johnson I. Fluorescent probes for living cells. Histochem J 30: 123, 1998.
22. Koya D and King G. Protein kinase C activation and the development of diabetic complications. Diabetes 47: 859-866, 1998.
23. Lander H, Tauras J, Ogiste J, Hori O, Moss R, and Schmidt A. Activation of the receptor for advanced glycation end products triggers ap21ras-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J Biol Chem 272: 17810-17814, 1997.
24. Li Y, Mitsuhashi T, Wojciechowicz D, Shimizu N, Li J, Stitt A, He C, Banerjee D, and Vlassara H. Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins. Proc Natl Acad Sci USA 93: 11047-11052, 1996.
25. Makita Z, Vlassara H, Cerami A, and Bucala R. Immunochemical detection of advanced glycosylation end products in vivo. J Biol Chem 267: 5133-5138, 1992.
26. McCarty M. A central role for protein kinase C overactivity in diabetic glomerulosclerosis:implications for prevention with antioxidants, fish oil and ACE inhibitors. Med Hypotheses 50: 155-165, 1998.
27. 2+ signaling of cultured human mesangial cells. J Am Soc Nephrol 10: 1478-1486, 1999.
28. Miyata T, Hori O, Zhang J, Yan S, Ferran L, Iida Y, and Schmidt A. The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-β2 microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyloid. J Clin Invest 98: 1088-1094, 1996.
29. Monnier V, Bautista O, Kenny D, Sell D, Fogarty J, Dahms W, Cleary P, Lachin J, and Genuth S. Skin collagen glycation, glycoxidation and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes. Diabetes 48: 870-880, 1999.
30. Pugliese G, Pricci F, Romeo G, Pugliese F, Mene P, Giannini S, Cresci B, Galli G, Rotella CM, Vlassara H, and Di Mario U. Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism. Diabetes 46: 1881-7, 1997.
31. Roisin M and Barbin G. Differential expression of PKC isoforms in hippocampal neuronal cultures: Modifications after basic FGF treatment. Neurochem Int 30: 261-270, 1997.
32. Saxena R, Saksa B, Fields A, and Ganz M. Activation of Na/H exchanger in mesangial cells is associated with translocation of PKC isoforms. Am J Physiol Renal Fluid Electrolyte Physiol 265: F53-F60, 1993.
33. II are differentially expressed in the developing glomerulus. FASEB J 8: 646-653, 1994.
34. Schmidt A, Crandall J, Hori O, Cao R, and Lakatta E. Elevated plasma levels of VCAM-1 in diabetic patients with microalbuminuria: a marker of vascular dysfunction and progressive vascular disease. Br J Haematol 92: 747-50, 1996.
35. Shanna K and Ziyadeh F. Hyperglycemia and diabetic kidney disease: the case for transforming growth factor-beta as a key mediator. Diabetes 44: 1139-1146, 1995.
36. Soulis T, Thallas V, Youssef S, Gilbert R, McWilliam B, Murray-McIntosh R, and Cooper M. Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury. Diabetologia 40: 619-628, 1997.
37. Suzuki D, Miyata T, Saotome N, Horie K, Inagi R, Yasuda Y, Uchida K, Izuhara Y, Yagame M, Sakai H, and Kurokawa K. Immunohistochemical evidence for an increased oxidative stress and carbonyl modifications of proteins in diabetic glomerular lesions. J Am Soc Nephrol 10: 822-832, 1999.
38. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl JMed 329: 977-86, 1993.
39. Yan S, Schmidt A, Anderson G, Zhang J, Brett J, Zou Y, Pinsky D, and Stern D. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem 269: 9889-9897, 1994.
40. Yang C, Vlassara H, Petern E, He C, Striker G, and Striker L. Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease. Proc Natl Acad Sci USA 91: 9436-9440, 1994.
41. Yoshida Y, Huang F, Nakabayashi H, and Huang K. Tissue distribution and developmental expression of protein kinase C isozymes. J Biol Chem 263: 9868-9873, 1988.